Navigation Links
Cephalon Reports Strong First Quarter Earnings
Date:5/1/2008

677,184

Total current liabilities 1,797,456 2,005,790

LONG-TERM DEBT 203,317 3,788

DEFERRED TAX LIABILITIES, net 75,860 56,540

OTHER LIABILITIES 143,020 138,084

Total liabilities 2,219,653 2,204,202

STOCKHOLDERS' EQUITY:

Common stock, $0.01 par value 701 700

Additional paid-in capital 1,951,294 1,934,965

Treasury stock, at cost (158,197) (158,173)

Accumulated deficit (585,277) (624,128)

Accumulated other comprehensive income 179,246 148,703

Total stockholders' equity 1,387,767 1,302,067

$3,607,420 $3,506,269

CEPHALON, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Three Months Ended

March 31,

2008 2007

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income $38,851 $75,185

Adjustments to reconcile net income

to net cash provided by operating

activities:

Deferred income tax expense 6,141 11,629

Shortfall tax benefits from stock-based

compensation - (83)

Depreciation and amortization 41,577 30,592

Amortization of debt issuance costs 60 60


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cephalon Appoints Gerald J. Pappert as General Counsel
2. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
3. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
4. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
5. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
6. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
7. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
8. Nu Skin Enterprises Reports First-Quarter 2008 Results
9. Cardinal Health Reports Third Quarter Results
10. BioMed Realty Trust Reports First Quarter 2008 Financial Results
11. Cardiac Science Reports Strong Q1 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Ill. One of the most popular vaccine brands ... And doctors may be overlooking some cost factors when ... a more expensive option, according to a new study ... vaccines to administer can be driven by numerous factors," ... and a professor of computer science and of mathematics ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary research ... Kenis in the Institute of Genomic Biology (IGB) ... Urbana-Champaign describe their recent work on subcellular redox ... cell functions including energy metabolism, signaling, and transcriptional ... normal cellular behavior, redox status has been recognized ...
(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... Medarex, Inc.,(Nasdaq: MEDX ) announced today its financial ... gain of $151.8 million, or $1.19 per share, from Medarex,s,sale ... 2008, Medarex,s,net income for the quarter ended March 31, 2008, ... net income of $110.3 million, or $0.88,per share for the ...
... MARKHAM, ON, May 12 /PRNewswire-FirstCall/ - Innolife Pharma, ... over the previous eight,months regarding the formation of ... in these negotiations where final written terms have ... to the Company,s very first,product acquisition. It should ...
... 12 The American Veterinary,Medical Association (AVMA) has reinforced ... horses and other equines by approving a,new policy on ... by the AVMA Executive Board on April 12, 2008,states ... AVMA opposes the,use of double-deck trailers to transport equines. ...
... The Myanmar Relief Fund,( http://www.MyanmarReliefFund.org ) is a ... the know-how to get aid in and directly ... are treating the,injured, and a myriad of supplies ... is a coalition of private American and Myanmar,citizens ...
... G.,Komen Pittsburgh Race for the Cure(R) are as follows:, 1st Place ... 15:14 Female: Kelly Knickelbein, Pittsburgh, Pa., 19:19, ... Burnett, 16:02 Female: Anna Beck, Washington, Pa., ... Charlie Ban, Pittsburgh, Pa., 16:13 Female: Jessica ...
... Better Care,Better Regulation, WASHINGTON, May 11 ... ManorCare nursing homes in sixteen states,across the nation ... a call to,action from quality care advocates. The ... Managing Director David Rubenstein to demand better,care. In ...
Cached Medicine News:Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture 2Health News:AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines 2Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Advocates Make Mother's Day Push for Quality Care 2
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... 2007 - ImmunoGen, Inc.,(Nasdaq: IMGN), a biopharmaceutical company ... (TAP),technology, today announced that clinical findings for three,different ... are to be,reported at the 43rd American Society ... June 1-5, 2007 in Chicago, IL., Trastuzumab-DM1 (abstract ...
... 2007 - GTx, Inc., (NASDAQ:,GTXI) announced today that ... clinical trial of Ostarine(TM) and from the ongoing ... for the treatment of multiple side effects of ... upcoming 2007,Annual Meeting of the American Society of ...
Cached Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3
Gentle-Flo® Standard Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
... and Increase Staff Protection With Medline's Sterile Suction ... Fr, 16 Fr and 18 Fr), ,Medline ... the U.S. We manufacture most of our suction ... exceeds our customers' expectations. We manufacture, supply and ...
... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...
... Catheters are available in two ... DeLee tip with staggered eyes, ... Two types of catheter valve ... easy fingertip control with virtually ...
Medicine Products: